2021
DOI: 10.1016/j.bmcl.2021.128202
|View full text |Cite
|
Sign up to set email alerts
|

Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…Patents relating to the inhibition of dipeptidylpeptidase using methano prolines as peptide constructs in 2001 by Bristol Myers Squibb were followed by many others securing the IP for saxaglyptin . Since then, cis- and trans-4,5-methano D- or L-prolines have become prime surrogates for compounds containing proline in medicinal chemistry applications, and covered extensively in the patent literature. Compounds 73 – 75 are a few representative examples (Figure ).…”
Section: Medicinal Chemistry-inspired Collaborations With Industry Ma...mentioning
confidence: 80%
“…Patents relating to the inhibition of dipeptidylpeptidase using methano prolines as peptide constructs in 2001 by Bristol Myers Squibb were followed by many others securing the IP for saxaglyptin . Since then, cis- and trans-4,5-methano D- or L-prolines have become prime surrogates for compounds containing proline in medicinal chemistry applications, and covered extensively in the patent literature. Compounds 73 – 75 are a few representative examples (Figure ).…”
Section: Medicinal Chemistry-inspired Collaborations With Industry Ma...mentioning
confidence: 80%
“…The synthesis commenced from hydroxymethyloxirane and after 5 stages provided the target prolines in a low 6-12% overall yield. 35 A series of 1,3-dipolar cycloaddition protocols are known to reach the discussed framework. The reported procedures generally involve the construction of spiroisoxazoline derivatives based on exo-CH 2prolines reacting with in situ generated nitrile oxides (III).…”
mentioning
confidence: 99%